Centre Tightens Hospital Safety Rules, Warns Against Reuse of Disposable Medical Equipment

NEW DELHI, October 24: The Centre has directed hospitals and other healthcare establishments across India to stop reusing medical devices and disposable surgical items designed for one-time use, citing concerns about patient safety, infection prevention and possible financial irregularities in medical billing.

The directive from the Directorate General of Health Services (DGHS) calls on state health authorities and drug regulators to strengthen enforcement and ensure that medical equipment is used according to the instructions issued by its original manufacturer. The intervention follows concerns that some hospitals, including private and corporate healthcare facilities, have been cleaning, sterilising and reusing products labelled for single use.

According to a report published on October 23, the DGHS issued a letter dated October 16 to state health secretaries, directors of health services, the Drug Controller General of India and state drug controllers. The communication highlighted the need for stricter oversight, particularly in specialised medical departments where disposable devices are used during invasive procedures.

The areas identified include cardiology, nephrology, oncology, cardiothoracic and vascular surgery, and neurosurgery. Equipment cited in the report includes cardiac catheters, guidewires, balloon and ablation catheters, introducer sheaths, dialysis equipment, surgical staplers, laparoscopic trocars and orthopaedic drill bits. Syringes and needles have also been identified among products reportedly subject to reuse.

The DGHS has emphasised that equipment intended for one procedure should not be subjected to reprocessing and used again when the manufacturer has designated it for single use. Authorities have been asked to ensure compliance with the applicable instructions and take action where violations are found.

Infection risks and patient safety concerns

Medical devices that enter the body or come into contact with blood and other biological material can carry infection risks if they are not handled correctly. Reusing products designed for one-time use can create additional hazards because their materials, construction and performance may not have been validated for repeated use.

Cleaning and sterilisation do not automatically make such products safe for another procedure. Some devices contain narrow channels, complex components or materials that can be damaged during reprocessing. Biological material may remain in inaccessible areas, while structural deterioration can affect a device’s performance.

The DGHS communication, as reported, warned of possible infections, including hepatitis B, hepatitis C, HIV and bacterial infections, alongside equipment malfunction and other complications. The risks depend on the device, how it has been handled and the circumstances of its reuse, but the central concern is that patients may be exposed to preventable harm.

Invasive procedures require particular attention because contaminated equipment can introduce infectious agents directly into the body or bloodstream. A device failure during a procedure may also interrupt treatment and require additional medical intervention.

The directive reinforces the importance of infection prevention and control practices throughout the healthcare system. Hospitals must ensure that staff members understand which products are intended for single use, follow the manufacturer’s labelling and instructions, and dispose of used items through appropriate biomedical waste procedures.

Concerns over hospital billing

Beyond clinical risks, the issue has raised questions about transparency in healthcare charges.

The DGHS reportedly noted that in some cases, patients may be billed the full cost of devices even when those products have been reused. Similar concerns were raised about reimbursement claims submitted to government authorities.

The matter is particularly significant for patients undergoing costly procedures, such as cardiac interventions, dialysis and cancer treatment. Medical bills can include charges for specialised equipment, consumables, hospital services and professional fees. Patients generally have limited ability to independently verify whether a device billed as a new item was actually used for the first time.

If a hospital charges for a single-use product but reuses it, questions arise about the accuracy of the bill, the disclosure provided to patients and whether the practice complies with applicable rules.

The DGHS action therefore addresses two connected issues: ensuring that equipment is used safely and improving accountability in the way hospitals document and charge for medical consumables.

The reported communication also refers to an earlier Central Government Health Scheme memorandum issued on December 21, 2016, concerning the reuse of such devices in hospitals empanelled under the scheme. The latest intervention indicates that stronger implementation and oversight remain necessary.

Regulators asked to strengthen enforcement

State and Union Territory health authorities, along with drug regulators, have been asked to ensure effective implementation of the instructions. The reported communication also points to the possibility of inspections and action under applicable laws and regulations.

Effective enforcement would require hospitals to maintain reliable records showing when devices are purchased, used and discarded. Such documentation can help establish whether a product intended for one-time use has been used more than once and can assist regulators in investigating complaints.

Hospitals may also need to review their procurement systems, inventory controls, operating procedures and staff training. Clear internal responsibilities can help prevent used products from being returned to clinical areas or incorrectly recorded as unused stock.

The Association of Indian Medical Device Industry (AiMeD), which represents domestic medical device manufacturers, welcomed the directive. The industry body has argued that products designed and validated for a single procedure should not be cleaned, resterilised or reused against their labelled instructions.

AiMeD has also called for regular inspections, traceable records covering device use and disposal, and appropriate training for hospital personnel in infection prevention and biomedical waste management.

The industry body has raised the question of responsibility when a device is reused contrary to the manufacturer’s instructions. Its position is that manufacturers should not automatically be held responsible for failures or injuries caused by the unauthorised reuse of their products.

These concerns underline the need for clear accountability across the supply chain, including manufacturers, distributors, healthcare establishments and clinical staff. Any investigation into a suspected violation would need to establish what the product instructions required, how the device was handled and who was responsible for the decision to reuse it.

Balancing patient protection and healthcare costs

Hospitals operate under financial pressures, and medical consumables can contribute significantly to the cost of treatment. However, reducing expenditure through practices that contradict a device’s approved instructions can expose patients to avoidable risks.

The industry body has called for support for safe and affordable single-use alternatives so that cost pressures do not encourage improper reuse. Improving procurement efficiency, maintaining transparent inventories and reducing unnecessary wastage may offer safer ways to manage expenses.

Patients also need clear information about the procedures they undergo and the charges appearing on their bills. Healthcare providers should maintain records that can be reviewed when concerns arise, while grievance mechanisms should enable patients to raise questions without compromising their ongoing care.

At the regulatory level, consistent implementation across public and private institutions will be important. Differences in inspection practices or enforcement between states could undermine the effectiveness of the national directive.

The DGHS intervention places renewed emphasis on following manufacturers’ instructions and ensuring that medical equipment is handled in ways that protect patients. Its impact will depend on how effectively state authorities translate the guidance into routine inspections, transparent documentation and corrective action.

For patients, the immediate issue is straightforward: equipment designed for one-time use should be handled in accordance with its intended purpose. For hospitals and regulators, the challenge is to ensure that patient safety, responsible disposal and accurate billing remain integral parts of medical care.